Skip to content

Recent Press Releases

Jul 25, 2014

Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema  

Jul 21, 2014

Allergan Reports Second Quarter 2014 Operating Results  

Jul 18, 2014

Allergan Announces Quarterly Conference Call  

Jul 14, 2014

Allergan Files Investor Presentation  

Jul 11, 2014

Allergan Comments on Pershing Square's Definitive Proxy Solicitation  

Jun 30, 2014

Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET  

Jun 23, 2014

Allergan Board of Directors Unanimously Rejects Unsolicited Exchange Offer from Valeant  

Jun 18, 2014

Allergan Board of Directors to Review Unsolicited Exchange Offer from Valeant  

Jun 16, 2014

Allergan Reiterates its Belief that Valeant's Business Model is Unsustainable  

Jun 10, 2014

Allergan Board Unanimously Rejects Revised Unsolicited Proposal from Valeant  

Jun 2, 2014

Allergan Comments on Pershing Square's and Valeant's Attempt to Remove a Majority of the Members of the Allergan Board of Directors  

May 30, 2014

Allergan Acknowledges Revised, Unsolicited Proposal from Valeant and Pershing Square  

May 28, 2014

Allergan Confirms Receipt of Revised, Unsolicited Proposal from Valeant  

May 27, 2014

Allergan Files Investor Presentation Detailing Concerns About the Sustainability of Valeant's Business Model  

May 20, 2014

Allergan Physician Customers Voice Strong Support Following Allergan's Rejection of Unsolicited Proposal to Acquire Company  

May 16, 2014

The Urology Care Foundation and Allergan Promote Patient Education and Advocacy at the 2014 American Urological Association Meeting  

May 12, 2014

Allergan Board Unanimously Rejects Unsolicited Proposal from Valeant  

May 8, 2014

Allergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)  

May 7, 2014

Allergan Reports First Quarter 2014 Operating Results  

May 6, 2014

BOTOX® (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients  

Showing 1-20 of 378
Page: 1 2 3 ... 19
 Next 20